EPISODE · Jan 15, 2019 · 18 MIN
Pharma raises its bet on biotech
from Behind the Money
In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. Read more from Sarah at FT.com. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Pharma raises its bet on biotech
0:00
18:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Behind the Money?
This episode is 18 minutes long.
When was this Behind the Money episode published?
This episode was published on January 15, 2019.
Can I download this Behind the Money episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!